This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
AstraZeneca (AZN.L) – A report stated that AstraZeneca offered to buy Japanese drug maker Daiichi Sankyo Co last year. The stock price soared before trade was suspended. The online version of Nikkei Business magazine, citing unidentified sources, said Daiichi Sankyo declined the offer. Closing price 4453.00p (Reuters)
Dunelm Group Plc (DLNM.L) – CEO John Browett is stepping down with immediate effect. After the decline in sterling, rising costs, the EU vote and consumer demand dropping, Chairman Andy Harrison will fill the CEO role on an interim basis. The company said its “next phase of growth requires different leadership’’. Closing price 573.50p (Bloomberg)
Hays PLC (HAYS.L) – Announced full-year operating profit rose 17% to £211.5m, broadly in line with its July estimate of £209.5m, and declared a special dividend of 4.25pp share. Supported by growth in continental Europe and improving hiring trends in the U.K. as the impact of the Brexit vote faded. Closing price 172.80p (Bloomberg)
Ladbrokes Coral Group PLC (LCL.L) – Report a marginal miss on H1 group revenue £1.20bn against estimates of £1.21bn YoY. Digital revenue climbed in the half but came in slower YoY. The company is confident on its outlook for H2 and has doubled its interim dividend to 2pp share. Closing price 117.60p (Bloomberg)
For more information on any of these individual news items, call into the trading floor
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research